Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-09-15 Other |
2021-09-17 1:38 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director |
0 | $0 | 50,468 (Indirect) |
View |
2021-06-18 Option Award |
2021-06-22 4:49 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director |
15,700 | $0 | 15,700 (Direct) |
View |
2021-06-10 Other |
2021-06-14 4:23 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director |
0 | $0 | 35,979 (Indirect) |
View |
2021-03-11 Other |
2021-03-15 4:15 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director |
0 | $0 | 25,066 (Indirect) |
View |
2020-11-11 Other |
2020-11-13 8:19 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director |
0 | $0 | 9,917 (Indirect) |
View |
2020-06-26 Option Award(A) |
2020-07-02 7:37 pm |
N/A 2030-06-26 |
Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director |
15,700 | $0 | 15,700 (Direct) |
View |
2020-06-26 Option Award |
2020-06-29 7:35 pm |
N/A 2030-06-26 |
Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director |
13,550 | $0 | 13,550 (Direct) |
View |